Opening book details…
About this Medicine article
O-185 Overcoming hypothesized antagonism with intermittent dosingof erlotinib in combination with docetaxel (DOC) in non-small cell lung cancer (NSCLC): A phase I study by Davies, A.; Lara, P.; Lau, D.; Mack, P.; Gumerlock, P.; Gandara, D. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Davies, A.; Lara, P.; Lau, D.; Mack, P.; Gumerlock, P.; Gandara, D.
- Publisher
- Elsevier Science; Elsevier ; Elsevier BV (ISSN 0169-5002)
- Published
- 2005
- Language
- EN
- Field
- Medicine (Health Sciences)
More by Davies, A.; Lara, P.; Lau, D.; Mack, P.; Gumerlock, P.; Gandara, D.
Browse all works by Davies, A.; Lara, P.; Lau, D.; Mack, P.; Gumerlock, P.; Gandara, D.